Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | leucine-rich repeat kinase 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | leucine rich repeat serine:threonine protein | Get druggable targets OG5_131478 | All targets in OG5_131478 |
Loa Loa (eye worm) | TKL/LRRK protein kinase | Get druggable targets OG5_131478 | All targets in OG5_131478 |
Echinococcus granulosus | leucine rich repeat serine:threonine protein | Get druggable targets OG5_131478 | All targets in OG5_131478 |
Brugia malayi | Protein kinase domain containing protein | Get druggable targets OG5_131478 | All targets in OG5_131478 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.0378 | 1 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | 0.0143 | 0.3745 | 0.3745 |
Leishmania major | hypothetical protein, conserved | 0.0003 | 0 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.007 | 0.1796 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 3 | 0.0143 | 0.3745 | 0.3745 |
Entamoeba histolytica | hypothetical protein | 0.0003 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0003 | 0 | 0.5 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.0378 | 1 | 1 |
Trypanosoma cruzi | Rab-like 5, small G protein | 0.0003 | 0 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.0378 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0003 | 0 | 0.5 |
Echinococcus granulosus | leucine rich repeat serine:threonine protein | 0.0071 | 0.1809 | 1 |
Onchocerca volvulus | 0.0003 | 0 | 0.5 | |
Onchocerca volvulus | Mitochondrial Rho GTPase homolog | 0.0003 | 0 | 0.5 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.0378 | 1 | 1 |
Trypanosoma brucei | Rab-like 5, small G protein | 0.0003 | 0 | 0.5 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.0378 | 1 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0234 | 0.6175 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0003 | 0 | 0.5 |
Toxoplasma gondii | cathepsin CPC1 | 0.0378 | 1 | 1 |
Loa Loa (eye worm) | TKL/LRRK protein kinase | 0.007 | 0.1796 | 1 |
Echinococcus multilocularis | leucine rich repeat serine:threonine protein | 0.007 | 0.1796 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0003 | 0 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.0378 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0003 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.12 uM | Inhibition of GST-tagged LRRK2 G2019S mutant (970-2527 amino acids) (unknown origin) assessed as inhibition of LRRKtide phosphorylation by HTRF assay | ChEMBL. | 23453068 |
IC50 (binding) | = 0.281 uM | Inhibition of wild type GST-tagged LRRK2 (970-2527 amino acids)(unknown origin) assessed as inhibition of LRRKtide phosphorylation by HTRF assay | ChEMBL. | 23453068 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.